Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. [electronic resource]
Producer: 20020614Description: 1219-28 p. digitalISSN:- 0006-2952
- Adaptor Proteins, Signal Transducing
- Adenosine Triphosphatases -- biosynthesis
- Antineoplastic Agents, Alkylating -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Carrier Proteins
- Cell Cycle -- drug effects
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins -- biosynthesis
- DNA Repair Enzymes
- DNA-Binding Proteins -- biosynthesis
- Dacarbazine -- analogs & derivatives
- Doxorubicin -- pharmacology
- Drug Interactions
- Drug Resistance, Multiple -- physiology
- Drug Screening Assays, Antitumor
- Glioma -- pathology
- Guanine -- analogs & derivatives
- Humans
- Mismatch Repair Endonuclease PMS2
- MutL Protein Homolog 1
- Neoplasm Proteins -- biosynthesis
- Nuclear Proteins
- O(6)-Methylguanine-DNA Methyltransferase -- metabolism
- Paclitaxel -- pharmacology
- Phenotype
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Temozolomide
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.